|
|
| (8 intermediate revisions by the same user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #Redirect [[High density lipoprotein classification]] |
| {{High density lipoprotein}}
| |
| {{CMG}} ;{{AE}} {{MM}}
| |
| | |
| ==Overview==
| |
| Low HDL level cut-off point has been a debate in many surveys. Most recently, it was set to be below 1.0 mmol/L (40 mg/dL) in both men and women.<ref name="pmid12485966">{{cite journal| author=National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)| title=Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. | journal=Circulation | year= 2002 | volume= 106 | issue= 25 | pages= 3143-421 | pmid=12485966 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12485966 }} </ref>
| |
| | |
| ==Definition==
| |
| Low HDL level cut-off point has been subjected recently to variable changes. In the Pan-European survey of HDL-cholesterol set out to determine the prevalence of low HDL-cholesterol, they defined the low HDL cut-off by level below 1.03 mmol/L (40 mg/dL) in men, and 1.29 mmol/L (50 mg/dL)in women,<ref>{{Cite web | last = | first = | title = Defining the prevalence of low HDL-C in a European cohort of dyslipidaemic patients | url = http://eurheartjsupp.oxfordjournals.org/content/7/suppl_F/F23.full?sid=70412a9e-1bf7-486e-90a9-0ae32b4ad6b1 | publisher = | date = | accessdate = 20 September 2013 }} </ref> but the clear risk of cardiovascular disease at levels above 35 mg/dL led the [[Adult Treatment Panel guidelines (ATP III)]] panel to recognize a higher cut-off for low HDL, they considered a level <40 mg/dL in both men and women. ATP III also rejected the idea to Set a different cut-point for low HDL cholesterol in men and women, and explained this rejection by the probability that it would make many women who are otherwise at low risk eligible for LDL-lowering drugs.<ref name="pmid12485966">{{cite journal| author=National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)| title=Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. | journal=Circulation | year= 2002 | volume= 106 | issue= 25 | pages= 3143-421 | pmid=12485966 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12485966 }} </ref>
| |
| | |
| ==References==
| |
| {{Reflist|2}}
| |
| | |
| {{Lipopedia}}
| |
| | |
| [[Category:Lipopedia]]
| |
| [[Category:Lipid disorders]]
| |
| [[Category:Cardiology]]
| |
| [[Category:Lipoproteins]]
| |
| | |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |